With Another Push From Eisai, Can Arena’s Belviq Be A Blockbuster?
This article was originally published in The Pink Sheet Daily
Executive Summary
The Japanese pharma has expanded its collaboration with Arena for the obesity treatment Belviq, but the drug is off to a slow start in a market full of non-starters.